Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Johnsson

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Langmuir : the ACS Journal of Surfaces and Colloids|June 28, 2006
"Sponge" nanoparticle dispersions in aqueous mixtures of diglycerol monooleate, glycerol dioleate, and polysorbate 80Justas Barauskas, Audrius Misiunas, Torsten Gunnarsson, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 2, 2008
A combined in vitro and in vivo study on the interactions between somatostatin and lipid-based liquid crystalline drug carriers and bilayersCamilla Cervin, Pauline Vandoolaeghe, Catalin Nistor, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|August 29, 2009
Interaction between lamellar (vesicles) and nonlamellar lipid liquid-crystalline nanoparticles as studied by time-resolved small-angle X-ray diffractionPauline Vandoolaeghe, Justas Barauskas, Markus Johnsson, et al.
Advances in Therapy|January 11, 2017
Pharmacokinetic Evaluation of Once-Weekly and Once-Monthly Buprenorphine Subcutaneous Injection Depots (CAM2038) Versus Intravenous and Sublingual Buprenorphine in Healthy Volunteers Under Naltrexone Blockade: An Open-Label Phase 1 StudyMuna Albayaty, Margareta Linden, Håkan Olsson, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 17, 2010
Properties and effects of a novel liquid crystal nanoparticle formulation of docetaxel in a prostate cancer mouse modelCamilla Cervin, Martina Tinzl, Markus Johnsson, et al.
Clinical Pharmacokinetics|May 26, 2025
Population Pharmacokinetic Analysis of an Octreotide Depot (CAM2029) in the Treatment of AcromegalyAnaïs Glatard, Sofia Friberg-Hietala, Lina Keutzer, et al.
International Journal of Pharmaceutics|March 11, 2010
Interactions of lipid-based liquid crystalline nanoparticles with model and cell membranesJustas Barauskas, Camilla Cervin, Marija Jankunec, et al.
Bioconjugate Chemistry|July 18, 2002
Development of EGF-conjugated liposomes for targeted delivery of boronated DNA-binding agentsErika Bohl Kullberg, Nill Bergstrand, Jörgen Carlsson, et al.
British Journal of Clinical Pharmacology|June 16, 2015
Octreotide s.c. depot provides sustained octreotide bioavailability and similar IGF-1 suppression to octreotide LAR in healthy volunteersFredrik Tiberg, John Roberts, Camilla Cervin, et al.
Advanced Materials (Deerfield Beach, Fla.)|March 17, 2025
Formulation and Characterization of Novel Ionizable and Cationic Lipid Nanoparticles for the Delivery of Splice-Switching OligonucleotidesMiina Ojansivu, Hanna M G Barriga, Margaret N Holme, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Langmuir : the ACS Journal of Surfaces and Colloids|June 28, 2006
"Sponge" nanoparticle dispersions in aqueous mixtures of diglycerol monooleate, glycerol dioleate, and polysorbate 80Justas Barauskas, Audrius Misiunas, Torsten Gunnarsson, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 2, 2008
A combined in vitro and in vivo study on the interactions between somatostatin and lipid-based liquid crystalline drug carriers and bilayersCamilla Cervin, Pauline Vandoolaeghe, Catalin Nistor, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|August 29, 2009
Interaction between lamellar (vesicles) and nonlamellar lipid liquid-crystalline nanoparticles as studied by time-resolved small-angle X-ray diffractionPauline Vandoolaeghe, Justas Barauskas, Markus Johnsson, et al.
Advances in Therapy|January 11, 2017
Pharmacokinetic Evaluation of Once-Weekly and Once-Monthly Buprenorphine Subcutaneous Injection Depots (CAM2038) Versus Intravenous and Sublingual Buprenorphine in Healthy Volunteers Under Naltrexone Blockade: An Open-Label Phase 1 StudyMuna Albayaty, Margareta Linden, Håkan Olsson, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 17, 2010
Properties and effects of a novel liquid crystal nanoparticle formulation of docetaxel in a prostate cancer mouse modelCamilla Cervin, Martina Tinzl, Markus Johnsson, et al.
Clinical Pharmacokinetics|May 26, 2025
Population Pharmacokinetic Analysis of an Octreotide Depot (CAM2029) in the Treatment of AcromegalyAnaïs Glatard, Sofia Friberg-Hietala, Lina Keutzer, et al.
International Journal of Pharmaceutics|March 11, 2010
Interactions of lipid-based liquid crystalline nanoparticles with model and cell membranesJustas Barauskas, Camilla Cervin, Marija Jankunec, et al.
Bioconjugate Chemistry|July 18, 2002
Development of EGF-conjugated liposomes for targeted delivery of boronated DNA-binding agentsErika Bohl Kullberg, Nill Bergstrand, Jörgen Carlsson, et al.
British Journal of Clinical Pharmacology|June 16, 2015
Octreotide s.c. depot provides sustained octreotide bioavailability and similar IGF-1 suppression to octreotide LAR in healthy volunteersFredrik Tiberg, John Roberts, Camilla Cervin, et al.
Advanced Materials (Deerfield Beach, Fla.)|March 17, 2025
Formulation and Characterization of Novel Ionizable and Cationic Lipid Nanoparticles for the Delivery of Splice-Switching OligonucleotidesMiina Ojansivu, Hanna M G Barriga, Margaret N Holme, et al.
Pageof 2